Structure Therapeutics (GPCR) PT Lowered to $70 at H.C. Wainwright
Positive target update
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Positive target update
What happened, with direct paths to the underlying reporting
Target $70; Price $41.53; Firm H.C. Wainwright; Analyst Ananda Ghosh.
Target: $70
Posted price: $41.53
Analyst firm: H.C. Wainwright
Analyst: Ananda Ghosh
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.